"I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),” said Mr.

Germany's artificial pancreas device system market, with a 4.1% CAGR from 2025-2035, leads Europe due to high <a target=_blank href= ...